NATCO PHARMA Q3 FY25 Results
NATCO PHARMA has released its financial results for the Q3 quarter of Financial Year 24-2025. Here's a comprehensive breakdown of the company's performance:
Revenue Analysis
- Current Quarter Revenue: Rs. 474.80 Cr
- Quarter-on-Quarter (QoQ) Change: -65.37% (Previous Quarter: Rs. 1,371.10 Cr )
- Year-on-Year (YoY) Change: -37.41% (Same Quarter Last Year: Rs. 758.60 Cr )
Profitability Metrics
- Net Profit: Rs. 132.40 Cr
- QoQ Profit Change: -80.43% (Previous Quarter: Rs. 676.50 Cr )
- YoY Profit Change: -37.75% (Same Quarter Last Year: Rs. 212.70 Cr )
Shareholder Returns
- Earnings Per Share (EPS): Rs. 7.43
- QoQ EPS Change: -80.35% (Previous Quarter: Rs. 37.81)
- YoY EPS Change: -37.46% (Same Quarter Last Year: Rs. 11.88)
Performance Summary
Challenging
NATCO PHARMA faced significant challenges with both sales and profits declining sharply. This might reflect tough market conditions or internal changes.
This analysis provides a snapshot of NATCO PHARMA's financial performance. Investors and analysts should consider these results in the context of broader market trends and the company's long-term strategy.
Disclaimer:
This information is for informational purposes only. Please reverify all details from official sources before making any financial decisions. The accuracy and completeness of this data cannot be guaranteed.